ProShare Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-48,765
Closed -$294K 1763
2019
Q4
$294K Sell
48,765
-4,571
-9% -$26.5K ﹤0.01% 1347
2019
Q3
$192K Sell
53,336
-1,553
-3% -$5.99K ﹤0.01% 1452
2019
Q2
$147K Sell
54,889
-6,984
-11% -$20.6K ﹤0.01% 1493
2019
Q1
$183K Buy
61,873
+562
+0.9% +$1.38K ﹤0.01% 1493
2018
Q4
$97K Sell
61,311
-11,837
-16% -$33.5K ﹤0.01% 1478
2018
Q3
$269K Sell
73,148
-2,903
-4% -$8.65K ﹤0.01% 1425
2018
Q2
$215K Sell
76,051
-5,036
-6% -$17.2K ﹤0.01% 1573
2018
Q1
$301K Sell
81,087
-10,553
-12% -$34.5K ﹤0.01% 1319
2017
Q4
$264K Buy
91,640
+6,567
+8% +$23.9K ﹤0.01% 1477
2017
Q3
$382K Buy
85,073
+4,554
+6% +$20.2K ﹤0.01% 1061
2017
Q2
$370K Sell
80,519
-5,943
-7% -$23.9K ﹤0.01% 1067
2017
Q1
$364K Sell
86,462
-22,657
-21% -$94.1K ﹤0.01% 1156
2016
Q4
$451K Buy
109,119
+11,343
+12% +$60.3K 0.01% 1128
2016
Q3
$792K Sell
97,776
-18,273
-16% -$155K 0.01% 755
2016
Q2
$905K Buy
116,049
+524
+0.5% +$4.5K 0.01% 752
2016
Q1
$892K Sell
115,525
-11,398
-9% -$83.5K 0.01% 740
2015
Q4
$1.37M Buy
126,923
+11,681
+10% +$106K 0.02% 633
2015
Q3
$796K Buy
115,242
+6,476
+6% +$52.8K 0.01% 755
2015
Q2
$964K Sell
108,766
-5,154
-5% -$48.8K 0.01% 793
2015
Q1
$1.12M Buy
113,920
+27,068
+31% +$338K 0.01% 791
2014
Q4
$1.06M Sell
86,852
-1,635
-2% -$20K 0.01% 824
2014
Q3
$883K Sell
88,487
-16,997
-16% -$158K 0.01% 1117
2014
Q2
$799K Sell
105,484
-66,278
-39% -$264K 0.01% 1277
2014
Q1
$565K Buy
171,762
+122,138
+246% +$427K 0.01% 1774
2013
Q4
$165K Sell
49,624
-45,312
-48% -$131K ﹤0.01% 1273
2013
Q3
$287K Buy
94,936
+29,210
+44% +$200K 0.01% 1927
2013
Q2
$538K Buy
+65,726
New +$502K 0.01% 1277